GENEMEDICINE CO LTD has a total of 32 patent applications. It increased the IP activity by 180.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and telecommunications are PROVECS MEDICAL GMBH, USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES and 4D MOLECULAR THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 4 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Singapore | 3 | |
#8 | Russian Federation | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Telecommunications |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Telephonic communication |
# | Name | Total Patents |
---|---|---|
#1 | Yun Chae Ok | 28 |
#2 | Ahn Hyo Min | 13 |
#3 | Oh Eon Ju | 5 |
#4 | Li Yan | 4 |
#5 | Kim Tae Geuk | 4 |
#6 | Yun Chae-Ok | 4 |
#7 | Lee Jung-Sun | 2 |
#8 | Ahn Hyo-Min | 1 |
#9 | Kim Tae-Geuk | 1 |
#10 | Kim Joo-Hang | 1 |
Publication | Filing date | Title |
---|---|---|
CA3106093A1 | Anti-tumor composition | |
EP3733210A1 | Cell sheet for gene delivery | |
EP3552614A1 | Anticancer composition comprising recombinant adenovirus expressing degradation factor for extracellular matrix | |
EP3329934A1 | Antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegf |